Amag Pharmaceuticals (33) | Business Finance (8)

Browse by Subcategory

Recent Contracts

Supplemental Indenture, dated as of November 16, 2020, between AMAG Pharmaceuticals, Inc. and Wilmington Trust, National Association (Filed With SEC on November 17, 2020)
Asset Purchase Agreement, dated May 21, 2020, by and between AMAG Pharmaceuticals, Inc. and Millicent Pharma Limited (Filed With SEC on May 22, 2020)
Form of Non-Qualified Stock Option Agreement - Non-Plan Inducement Grant (Filed With SEC on May 11, 2020)
Contract Manufacturing Agreement, dated September 1, 2018, by and between AMAG Pharmaceuticals, Inc. and Fresenius Kabi Austria GmbH (Certain confidential information contained in... (Filed With SEC on March 1, 2019)
Supplemental Indenture, dated as of November 16, 2020, among AMAG Pharmaceuticals, Inc., Covis Finco S. r.l. and Wilmington Trust, National Association (Filed With SEC on November 17, 2020)
Supplemental Indenture, dated as of November 16, 2020, between AMAG Pharmaceuticals, Inc. and Wilmington Trust, National Association (Filed With SEC on November 17, 2020)
Supplemental Indenture, dated as of November 16, 2020, among AMAG Pharmaceuticals, Inc., Covis Finco S. r.l. and Wilmington Trust, National Association (Filed With SEC on November 17, 2020)
Form of Restricted Stock Unit Agreement - Non-Plan Inducement Grant (Filed With SEC on May 11, 2020)